Adult Immunization 2010 Hepatitis B Vaccine Segment

Slides:

Advertisements

Similar presentations

1 Chronic HBV: Current Management Natalie Bzowej, MD, PhD, FRCPC Director Transplant Research Ochsner Medical Center New Orleans, LA.

Advertisements

Treatment appropriate Normal or minimal hepatitis Chronic hepatitis Normal or inactive hepatitis Progressive fibrosis Cirrhosis HCC HBeAg Anti-HBe HBV.

Adult Immunization 2010 Hepatitis A Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

Hepatitis B Virus and Cancer Everett Schlam, MD 9/22/2011.

Hepatitis A Last updated August Hepatitis A virus Associated with poor hygiene and sanitation - primarily transmitted from person-to-person via.

A 23 year old business woman got two shots of hepatitis B 1 month apart 2 years ago. Today she is at your practice for ending the schedule. What should.

Hepatitis A and Hepatitis A Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.

Hepatitis B and Hepatitis B Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.

Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.

Adult Immunization 2010 Influenza Segment This material is in the public domain This information is valid as of May 25, 2010.

Vaccine Information Statement Hepatitis B (7/11/01) 42 U.S.C. § 300aa-26.

Smallpox Vaccine Contraindications and Screening Department of Health and Human Services Centers for Disease Control and Prevention December 2002 Note:

Adult Immunization 2010 MMR Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.

What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.

Measles and Measles Vaccine Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.

Source: National Notifiable Diseases Surveillance System (NNDSS)

Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.

Developed By: Barbara (Bobbi) P. Clarke, PhD. RD Professor & Extension Health Specialist, Co-Director for The University of Tennessee Center for Community.

Epidemiology and Prevention of Viral Hepatitis A to E: Hepatitis A Virus Division of Viral Hepatitis.

Viral Hepatitis & Serving Seniors in Community Health Centers Corinna Dan, RN, MPH Office of HIV/AIDS and Infectious Disease Policy U.S. Department of.

Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.

Wyoming Department of Health Communicable Diseases

Hepatitis B Virus 28.

Viral Hepatitis - Historical Perspective A “Infectious” “Serum” Viral hepatitis Entericallytransmitted Parenterallytransmitted F, G, ? other E NANB BD.

1 Hepatitis A and B Vaccination and the New York State Adult Hepatitis Vaccination Program Elizabeth Rausch-Phung, MD MPH Medical Director, NYSDOH Bureau.

Communicable Disease Aim: How can someone contract a communicable disease?

*Adjusted for underreporting. Source: National Notifiable Diseases Surveillance System (NNDSS)

Polio and Polio Vaccine

Adult Immunization 2010 Pneumococcal Segment This material is in the public domain This information is valid as of May 25, 2010.

Diphtheria and Diphtheria Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control.

MENINGOCOCCAL PNEUMOCOCCAL TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone starting at 6 mos old y/o.

Tetanus and Tetanus Toxoid Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases Centers.

0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 Number of cases Year Reported Acute Cases Adjusted Acute Cases * Adjusted for underreporting. Note: Until.

Immunization Update 2007 Satellite Broadcast/Webcast August 9, 2007 Influenza Vaccine Segment Graphics subject to change. This material in the public domain.

CURRENT HEALTH PROBLEMS IN STUDENT'S HOME SOUNTRIES HEPATITIS B IN MALAYSIA MOHD ZHARIF ABD HAMID AMINUDDIN BAKI AMRAN.

Blood borne Pathogens. Background  Occupational Safety and Health Administration (OSHA)  Blood borne pathogen standard developed December 6, 1991 

Viral Hepatitis Program Management of Babies Born to HBsAg- Positive Mothers Vickie Weeast Perinatal Hepatitis B Case.

MENINGOCOCCAL POLYSACCHARIDE PNEUMOCOCCAL POLYSACCHARIDE TETANUS, DIPHTHERIA, PERTUSSIS VARICELLA HEPATITIS A HEPATITIS B HUMAN PAPILLOMA VIRUS Anyone.

Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.

Hepatitis B and Hepatitis B Vaccine

Meningococcal Disease and Meningococcal Vaccines

Note to presenters: Images of vaccine-preventable diseases are available from the Immunization Action Coalition website at

SAMANTHA ALLEN PHARMACY STUDENT PHARMD CANDIDATE 2012 SEPTEMBER 27, 2011 Hepatitis B Vaccination in Cirrhotic Liver Transplant Candidates.

Chapter 14: Bloodborne Pathogens. Bloodborne pathogens are transmitted through contact with blood or other bodily fluids Hepatitis, especially hepatitis.

Resources for New Providers of Hepatitis B Vaccination in Alternative Settings Teresa A. Anderson, DDS, MPH National Immunization Conference May 12, 2004.

Haemophilus influenzae type B and Hib Vaccine

Date of download: 6/21/2016 From: Recommended Adult Immunization Schedule: United States, October 2007–September 2008(1) Ann Intern Med. 2007;147(10):

Viral hepatitis overview Itodo Ewaoche 27/02/2015.

Hepatitis A, B, C: Overview, Serologies, and Vaccination Connie Tien June 6, 2016.

Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.

Source: National Notifiable Diseases Surveillance System (NNDSS)

Adult Immunizations August 23, 2004 Vinod Kurup, MD

Guidelines for Vaccinating Dialysis Patients BY: DR. JONAIDI ASSOCIATE PROF. OF INFECTIOUS DISEASES.

Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2

Presenter ITODO EWAOCHE

Khaled Janom Ambulatory report

Immunization Update 2007 Rotavirus Vaccine Segment

The virus that does not cause chronic liver disease

is caused by the Hepatitis A virus (HAV)

Immunization Update 2007 Tdap Vaccine Segment

CDC’s Adult Hepatitis B Vaccination Initiative

RISK R isk of Perinatal and Early Childhood Infection

Hepatitis B Vaccination Assessment Adults Aged Years National Health Interview Survey, 2000 Gary L. Euler, DrPH1, Hussain Yusuf, MBBS2, Shannon.

Immunization Update 2007 Varicella Vaccine Segment

Progress in Facilitating National HCV Prevention

Smallpox Vaccine Contraindications and Screening

March 8, 2006 New ACIP Hepatitis B Recommendations

Presentation transcript:

Adult Immunization 2010 Hepatitis B Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010

Risk Factors for Hepatitis B CDC Sentinel Sites. 2001 data.

Hepatitis B Vaccine Long-Term Efficacy Immunologic memory develops following vaccination Antibody level declines following successful vaccination Anamnestic response upon exposure (antibody level increases quickly) Chronic infection rarely documented among vaccine responders MMWR 2006;55(RR-16)

Hepatitis B Vaccine Adult Schedule Usual Minimum Dose Interval Interval Primary 1 Primary 2 --- --- 1 month 4 weeks Primary 3 4-6 months 8 weeks* *third dose must be separated from first dose by at least 16 weeks MMWR 2006;55(RR-16)

Booster doses are NOT recommended routinely for any group Hepatitis B Vaccine Booster doses are NOT recommended routinely for any group MMWR 2006;55(RR-16)

Hepatitis B Vaccine Adult Candidates Men who have sex with men Heterosexual with multiple partners Persons seeking evaluation or treatment for a sexually transmitted disease Injection drug users Male prison inmates Persons with end-stage renal disease, including predialysis, hemodialysis, peritoneal dialysis, and home dialysis MMWR 2006;55(RR-16)

Hepatitis B Vaccine Adult Candidates Staff and clients in institutions for the developmentally disabled Persons with chronic liver disease Persons with HIV infection Household members and sex partners of persons with chronic HBV infection Persons who travel to HBV-endemic areas MMWR 2006;55(RR-16)

Hepatitis B Vaccine Contraindications and Precautions Severe allergic reaction to a vaccine component or following a prior dose Moderate or severe acute illness MMWR 2006;55(RR-16)

Hepatitis B Vaccine Adverse Reactions Pain at injection site 13%-29% Mild systemic complaints 11%-17% (fatigue, headache) Temperature >100oF 1% Severe systemic reactions rare MMWR 2006;55(RR-16)

National Center for Immunization and Respiratory Diseases Contact Information Telephone (800) CDC-INFO Email nipinfo@cdc.gov Website http://www.cdc.gov/vaccines/ Broadcast Updates and Resources Web Page http://www.cdc.gov/vaccines/ed/webcasts.htm